Previous Close | 1.3900 |
Open | 1.3700 |
Bid | 1.3700 x 500 |
Ask | 1.4200 x 600 |
Day's Range | 1.3600 - 1.4100 |
52 Week Range | 0.3600 - 1.9200 |
Volume | |
Avg. Volume | 2,448,566 |
Market Cap | 204.206M |
Beta (5Y Monthly) | -0.20 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Apr 28, 2014 |
1y Target Est | N/A |
Key Insights Veru's significant individual investors ownership suggests that the key decisions are influenced by...
Explore key insights from Veru Inc's Q2 2024 earnings, emphasizing improved financial management and strategic advancements in pharmaceutical development.
Veru's Innovative Clinical Programs Progress as Financial Challenges Persist